High materiality7/10
Monopar Therapeutics price target raised to $130 from $115 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises Monopar Therapeutics (MNPR) target to $130 from $115; current price $116.18.
- Target: $130
- Posted price: $116.18
- Analyst: Morgan Stanley
Key facts
- 01
Target: $130
- 02
Posted price: $116.18
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Maxwell Skor
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.